GERN - Geron Corporation
| Previous Close | 3.7900 |
| Open | 3.8000 |
| Bid | 4.1300 x 600 |
| Ask | 4.1400 x 2500 |
| Day's Range | 3.7500 - 4.2000 |
| 52 Week Range | 1.7400 - 6.6800 |
| Volume | 6,302,065 |
| Avg. Volume | 7,262,550 |
| Market Cap | 658.665M |
| Beta | 2.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings Date | May 4, 2017 - May 8, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.50 |
Yahoo Finance Video•5 days agoNYSE trader: Stocks are rallying on fundamentals and not the finger pointing in DC
Matthew Cheslock joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
- CNBC Videos•7 days ago
Cramer's lightning round: Take a long-term view on Spotif...
Jim Cramer shares his take on callers' favorite stocks at lightning speed, including a newly public streaming play.
Yahoo Finance Video•7 days agoMARKETS: These are the top risks CEOs are citing this earnings season
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance Video•11 days agoMARKETS: Bitcoin shorts obliterated on 11% surge
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.
Yahoo Finance Video•13 days agoMARKETS: Welcome to the low volume, low liquidity algo-driven market
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance Video•20 days agoMARKETS: Bulls need to avoid a closing bell selloff today
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance Video•21 days agoMARKETS: Why April could be a bad month for stocks
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.
- Motley Fool•4 hours ago
Geron Corporation: The Clock Is Ticking
Geron's stock has been a magnet for short-sellers, but the long thesis remains intact.
- Motley Fool•6 days ago
Why Geron Corporation's Stock Is Heading Higher Today
Geron's experimental blood cancer drug remains a top priority for the pharma behemoth Johnson & Johnson.
- GlobeNewswire•6 days ago
Geron 2018 Annual Meeting of Stockholders to be Held on May 15
MENLO PARK, Calif., April 17, 2018-- Geron Corporation will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May 15, 2018, at 4:00 p.m. PDT.. Geron’ s stockholders are invited to attend the Annual ...
- Zacks•7 days ago
Why Is Geron (GERN) Up 10.6% Since Its Last Earnings Report?
Geron (GERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•10 days ago
Here's Why Geron Stock Surged More Than 90% in 6 Months
Geron (GERN) telomerase inhibitor, imetelstat, is being evaluated in two late stage studies. The candidate is progressing well in the Janssen sponsored studies.
- ACCESSWIRE•10 days ago
Today’s Research Reports on Stocks to Watch: Geron Corp. and Rigel Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / April 13, 2018 / Rigel shares were popping on Thursday but unfortunately it was due to a mistake. The company corrected the mistake after-hours and announced that there had ...
Motley Fool•10 days agoWhy Geron Corporation Stock Popped 84% in March
The small-cap oncology biotech's stock is likely to see big movement next week.
- Simply Wall St.•10 days ago
Should You Worry About Geron Corporation’s (NASDAQ:GERN) CEO Pay Check?
Chip Scarlett took the reins as CEO of Geron Corporation’s (NASDAQ:GERN) and grew market cap to US$531.76M recently. Recognizing whether CEO incentives are aligned with shareholders is a crucial partRead More...
- Motley Fool•11 days ago
Why Geron Corporation Stock Is on the Rise Today
Geron's shares are on the move again today. Here's why.
- Motley Fool•14 days ago
3 Reasons This Clinical-Stage Biotech Is an Incredible Bargain
Geron's risk-to-reward ratio might be too juicy to pass up.
- ACCESSWIRE•18 days ago
GERON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Geron Corporation To Contact The Firm
NEW YORK, NY / ACCESSWIRE / April 5, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Geron Corporation ("Geron" or the "Company") ...
- Business Wire•20 days ago
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Geron Corporation Investors (GERN)
Glancy Prongay & Murray LLP announces an investigation on behalf of Geron Corporation investors concerning the Company and its officers’ possible violations of federal securities laws.
- Business Wire•20 days ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Geron Corporation
Levi & Korsinsky announces it has commenced an investigation of Geron Corporation concerning possible violations of federal securities laws.
- Motley Fool•21 days ago
Why Geron Corporation Stock Is Falling Today
Geron's stock can't seem to find a bottom.
- Motley Fool•21 days ago
Are Short-Sellers Right About Geron Corporation?
The short argument against Geron doesn't add up. Here's why.
- Motley Fool•25 days ago
Geron Corp. Skyrocketed and AbbVie Inc. Crashed -- Are These Stocks Buys?
Geron’s future hinges on an uncertainty and AbbVie’s teetering following disappointing news. Do these stocks deserve a place in your portfolio?
- ACCESSWIRE•25 days ago
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Geron Corporation
LOS ANGELES, CA / ACCESSWIRE / March 29, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Geron Corporation ...
Motley Fool•25 days agoThese 3 Biotech Stocks Are Soaring, but Are They Buys Now?
These highfliers could could climb higher. Here's what needs to happen.
